BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 20524682)

  • 1. Theoretical and experimental investigation on the solid solubility and miscibility of naproxen in poly(vinylpyrrolidone).
    Paudel A; Van Humbeeck J; Van den Mooter G
    Mol Pharm; 2010 Aug; 7(4):1133-48. PubMed ID: 20524682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relating hydrogen-bonding interactions with the phase behavior of naproxen/PVP K 25 solid dispersions: evaluation of solution-cast and quench-cooled films.
    Paudel A; Nies E; Van den Mooter G
    Mol Pharm; 2012 Nov; 9(11):3301-17. PubMed ID: 23009610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the molecular distribution of drugs in glassy solid dispersions at the nano-meter scale, using differential scanning calorimetry and gravimetric water vapour sorption techniques.
    van Drooge DJ; Hinrichs WL; Visser MR; Frijlink HW
    Int J Pharm; 2006 Mar; 310(1-2):220-9. PubMed ID: 16427226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can compression induce demixing in amorphous solid dispersions? A case study of naproxen-PVP K25.
    Ayenew Z; Paudel A; Van den Mooter G
    Eur J Pharm Biopharm; 2012 May; 81(1):207-13. PubMed ID: 22293573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-polymer miscibility across a spray dryer: a case study of naproxen and miconazole solid dispersions.
    Worku ZA; Aarts J; Singh A; Van den Mooter G
    Mol Pharm; 2014 Apr; 11(4):1094-101. PubMed ID: 24533891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase behavior of poly(vinylpyrrolidone) containing amorphous solid dispersions in the presence of moisture.
    Rumondor AC; Marsac PJ; Stanford LA; Taylor LS
    Mol Pharm; 2009; 6(5):1492-505. PubMed ID: 19634917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of spray drying and milling in the production of amorphous dispersions of sulfathiazole/polyvinylpyrrolidone and sulfadimidine/polyvinylpyrrolidone.
    Caron V; Tajber L; Corrigan OI; Healy AM
    Mol Pharm; 2011 Apr; 8(2):532-42. PubMed ID: 21323367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Theoretical and experimental investigation of drug-polymer interaction and miscibility and its impact on drug supersaturation in aqueous medium.
    Baghel S; Cathcart H; O'Reilly NJ
    Eur J Pharm Biopharm; 2016 Oct; 107():16-31. PubMed ID: 27378287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of molecular interaction in stability of celecoxib-PVP amorphous systems.
    Gupta P; Thilagavathi R; Chakraborti AK; Bansal AK
    Mol Pharm; 2005; 2(5):384-91. PubMed ID: 16196491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization and stability of solid dispersions based on PEG/polymer blends.
    Bley H; Fussnegger B; Bodmeier R
    Int J Pharm; 2010 May; 390(2):165-73. PubMed ID: 20132875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of polymer hygroscopicity on the phase behavior of amorphous solid dispersions in the presence of moisture.
    Rumondor AC; Taylor LS
    Mol Pharm; 2010 Apr; 7(2):477-90. PubMed ID: 20039693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An investigation into the effect of spray drying temperature and atomizing conditions on miscibility, physical stability, and performance of naproxen-PVP K 25 solid dispersions.
    Paudel A; Loyson Y; Van den Mooter G
    J Pharm Sci; 2013 Apr; 102(4):1249-67. PubMed ID: 23359268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation and correlation of drug polymer miscibility and molecular interactions by various approaches for the preparation of amorphous solid dispersions.
    Meng F; Trivino A; Prasad D; Chauhan H
    Eur J Pharm Sci; 2015 Apr; 71():12-24. PubMed ID: 25686597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of surfactants as plasticizers in preparing solid dispersions of poorly soluble API: selection of polymer-surfactant combinations using solubility parameters and testing the processability.
    Ghebremeskel AN; Vemavarapu C; Lodaya M
    Int J Pharm; 2007 Jan; 328(2):119-29. PubMed ID: 16968659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular dynamics simulation of amorphous indomethacin-poly(vinylpyrrolidone) glasses: solubility and hydrogen bonding interactions.
    Xiang TX; Anderson BD
    J Pharm Sci; 2013 Mar; 102(3):876-91. PubMed ID: 23280486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of solvent composition on the miscibility and physical stability of naproxen/PVP K 25 solid dispersions prepared by cosolvent spray-drying.
    Paudel A; Van den Mooter G
    Pharm Res; 2012 Jan; 29(1):251-70. PubMed ID: 21773852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction of drug-polymer thermodynamic phase diagrams using Flory-Huggins interaction theory: identifying the relevance of temperature and drug weight fraction to phase separation within solid dispersions.
    Tian Y; Booth J; Meehan E; Jones DS; Li S; Andrews GP
    Mol Pharm; 2013 Jan; 10(1):236-48. PubMed ID: 23110477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solid dispersions of itraconazole and enteric polymers made by ultra-rapid freezing.
    Overhoff KA; Moreno A; Miller DA; Johnston KP; Williams RO
    Int J Pharm; 2007 May; 336(1):122-32. PubMed ID: 17184938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physical stability of solid dispersions with respect to thermodynamic solubility of tadalafil in PVP-VA.
    Wlodarski K; Sawicki W; Kozyra A; Tajber L
    Eur J Pharm Biopharm; 2015 Oct; 96():237-46. PubMed ID: 26247119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Theoretical and practical approaches for prediction of drug-polymer miscibility and solubility.
    Marsac PJ; Shamblin SL; Taylor LS
    Pharm Res; 2006 Oct; 23(10):2417-26. PubMed ID: 16933098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.